MCID: ATM021
MIFTS: 19

Autoimmune Inner Ear Disease malady

Categories: Rare diseases, Ear diseases

Aliases & Classifications for Autoimmune Inner Ear Disease

About this section

Aliases & Descriptions for Autoimmune Inner Ear Disease:

Name: Autoimmune Inner Ear Disease 45
Ocular Albinism, Type Ii 65
 
Aied 45

Classifications:



External Ids:

UMLS65 C0268505

Summaries for Autoimmune Inner Ear Disease

About this section
Wikipedia:68 Autoimmune inner ear disease (AIED) was first defined by Dr. Brian McCabe in a landmark paper describing... more...

MalaCards based summary: Autoimmune Inner Ear Disease, also known as ocular albinism, type ii, is related to androgen insensitivity and aland island eye disease. Affiliated tissues include liver, placenta and endothelial.

Related Diseases for Autoimmune Inner Ear Disease

About this section

Graphical network of the top 20 diseases related to Autoimmune Inner Ear Disease:



Diseases related to autoimmune inner ear disease

Symptoms for Autoimmune Inner Ear Disease

About this section

Drugs & Therapeutics for Autoimmune Inner Ear Disease

About this section

Drugs for Autoimmune Inner Ear Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 18)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
MethotrexateapprovedPhase 314441959-05-2, 59-05-2126941
Synonyms:
4-amino-10-methylfolic acid
4-amino-N(10)-Methylpteroylglutamic acid
Abitrexate
Amethopterin
Amethopterine
Antifolan
Arbitrexate
Emtexate
Folex
HDMTX
L-Amethopterin
Ledertrexate
MTX
Metatrexan
Methopterin
Methotextrate
 
Methotrate
Methotrexat
Methotrexate
Methotrexate Sodium
Methotrexatum
Methylaminopterin
Methylaminopterinum
Metoject
Metotrexato
Mexate
Méthotrexate
N-Bismethylpteroylglutamic Acid
N-[4-[[(2,4-Diamino-6-pteridinyl)methyl]methylamino]benzoyl]-L-glutamic acid
Otrexup
Rasuvo
Rheumatrex
Rheumatrex Dose Pack
Trexall
2
Cyclophosphamideapproved, investigationalPhase 3264350-18-0, 6055-19-22907
Synonyms:
(+-)-Cyclophosphamide
(-)-Cyclophosphamide
(RS)-Cyclophosphamide
1-(bis(2-chloroethyl)amino)-1-oxo-2-aza-5-oxaphosphoridine
1-Bis(2-chloroethyl)amino-1-oxo-2-aza-5-oxaphosphoridin
2-[Bis(2-chloroethylamino)]-tetrahydro-2H-1,3,2-oxazaphosphorine-2-oxide
4-Hydroxy-cyclophosphan-mamophosphatide
50-18-0
60007-95-6
6055-19-2 (monohydrate)
75526-90-8
AC1L1EQQ
AI3-26198
ASTA
ASTA B518
Asta B 518
B 518
B-518
BRN 0011744
BSPBio_002099
Bis(2-chloroethyl)phosphoramide cyclic propanolamide ester
C 0768
C07888
C7H15Cl2N2O2P
CB 4564
CB-4564
CCRIS 188
CHEBI:4027
CHEMBL32520
CHEMBL88
CID2907
CP
CPA
CTX
CY
Ciclofosfamida
Ciclofosfamida [INN-Spanish]
Ciclofosfamide
Ciclophosphamide
Ciclophosphamide [INN]
Clafen
Claphene
Cycloblastin
Cyclophosphamid
Cyclophosphamide
Cyclophosphamide (INN)
Cyclophosphamide (TN)
Cyclophosphamide (anhydrous form)
Cyclophosphamide (anhydrous)
Cyclophosphamide Monohydrate
Cyclophosphamide Sterile
Cyclophosphamide anhydrous
Cyclophosphamide, (+-)-Isomer
Cyclophosphamides
Cyclophosphamidum
Cyclophosphamidum [INN-Latin]
Cyclophosphan
Cyclophosphane
Cyclophosphanum
Cyclophosphoramide
Cyclostin
Cyklofosfamid
Cyklofosfamid [Czech]
Cytophosphan
Cytophosphane
Cytoxan
Cytoxan (TN)
Cytoxan Lyoph
D,L-Cyclophosphamide
D07760
DB00531
 
DivK1c_000246
EINECS 200-015-4
EU-0100238
Endoxan
Endoxan R
Endoxan-Asta
Endoxana
Endoxanal
Endoxane
Enduxan
Genoxal
HMS2090A12
HSDB 3047
Hexadrin
IDI1_000246
KBio1_000246
KBio2_001338
KBio2_003906
KBio2_006474
KBio3_001319
KBioGR_000888
KBioSS_001338
LS-1302
LS-99787
Ledoxina
Lopac-C-0768
Lopac0_000238
Lyophilized Cytoxan
Mitoxan
MolPort-001-783-420
N,N-Bis(2-chloroethyl)-1,3,2-oxazaphosphinan-2-amine 2-oxide
N,N-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide
NCGC00015209-01
NCGC00015209-03
NCGC00015209-06
NCGC00091741-02
NCGC00091741-03
NCI-C04900
NCI60_002097
NINDS_000246
NSC 26271
NSC-26271
NSC26271
NSC273033
NSC273034
Neosar
Occupation, cyclophosphamide exposure
Procytox
RCRA waste no. U058
Rcra Waste Number U058
Rcra waste number U058
Revimmune
S1217_Selleck
SK 20501
SPBio_001071
STK177249
STOCK2S-91217
Semdoxan
Sendoxan
Senduxan
Spectrum2_001146
Spectrum3_000370
Spectrum4_000304
Spectrum5_000795
Spectrum_000858
UNII-6UXW23996M
WLN: T6MPOTJ BO BN2G2G
Zyklophosphamid
Zyklophosphamid [German]
bis(2-Chloroethyl)phosphami de cyclic propanolamide
bis(2-Chloroethyl)phosphamide cyclic propanolamide ester
cyclophosphamide
3
PrednisoneapprovedPhase 3126753-03-25865
Synonyms:
(1S,2R,10S,11S,14R,15S)-14-hydroxy-14-(2-hydroxyacetyl)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-3,6-diene-5,17-dione
(8S,9S,10R,13S,14S,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,9,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,11-dione
(8xi,9xi,14xi)-17,21-dihydroxypregna-1,4-diene-3,11,20-trione
.delta. E
.delta.(sup1)-Cortisone
.delta.-Cortelan
.delta.-Cortisone
.delta.-Cortone
.delta.-E
.delta.1-Cortisone
.delta.1-Dehydrocortisone
.delta.sone
1,2-Dehydrocortisone
1,4-Pregnadiene-17-alpha,21-diol-3,11,20-trione
1,4-Pregnadiene-17.alpha.,21-diol-3,11,20-trione
1,4-Pregnadiene-17alpha,21-diol-3,11,20-trione
1-Cortisone
1-Dehydrocortisone
17,21-Dihydroxypregna-1,4-diene-3,11,20-trione
17alpha,21-Dihydroxy-1,4-pregnadiene-3,11,20-trione
53-03-2
68-59-7
81552_FLUKA
AC-11112
AC1L1LB2
AC1Q29EZ
ACon0_000082
ACon1_000297
AI3-52939
Adasone
Ancortone
Apo-Prednisone
Apo-prednisone
BPBio1_000323
BRD-K85883481-001-04-2
BSPBio_000293
Betapar
Bicortone
Bio-0649
C07370
C21H26O5
CCRIS 2646
CHEBI:8382
CHEMBL635
CID5865
CPD001227202
Cartancyl
Colisone
Cortan
Cortancyl
Cortidelt
Cotone
DB00635
Dacorten
Dacortin
Decortancyl
Decortin
Decortisyl
Dehydrocortisone
Dekortin
Delcortin
Dellacort
Dellacort A
Delta Cortelan
Delta E
Delta E.
Delta-Cortelan
Delta-Dome
Delta-cortelan
Delta-cortisone
Delta-cortone
Delta-dome
Deltacortene
Deltacortisone
Deltacortone
Deltasone
Deltasone, Liquid Pred, Orasone, Adasone, Deltacortisone,Prednisone
Deltison
Deltisona
Deltisone
Deltra
Di-Adreson
Diadreson
EINECS 200-160-3
Econosone
Encorton
Encortone
Enkortolon
Enkorton
Fernisone
Fiasone
HMS1568O15
HMS2090J13
HSDB 3168
Hostacortin
In-Sone
Incocortyl
Juvason
 
Kortancyl
LMST02030180
LS-1325
Liquid Pred
Lisacort
Lodotra
MEGxm0_000443
MLS001061265
MLS001304073
MLS001335907
MLS001335908
MLS002154191
MLS002207083
Me-Korti
Metacortandracin
Meticorten
Meticorten (Veterinary)
Metrevet (Veterinary)
MolPort-001-740-041
NCGC00090766-01
NCGC00090766-02
NCGC00090766-03
NCI-C04897
NCI60_000008
NSC 10023
NSC10023
Nisona
Nizon
Novoprednisone
Nurison
Orasone
Origen Prednisone
P1276
P6254_SIGMA
PRD
Panafcort
Panasol
Paracort
Parmenison
Pehacort
Perrigo Prednisone
Precort
Predeltin
Prednicen-M
Prednicorm
Prednicort
Prednicot
Prednidib
Prednilonga
Prednison
Prednisona
Prednisona [INN-Spanish]
Prednisone
Prednisone Intensol
Prednisone [INN:BAN]
Prednisonum
Prednisonum [INN-Latin]
Prednitone
Prednizon
Prednovister
Presone
Prestwick0_000077
Prestwick1_000077
Prestwick2_000077
Prestwick3_000077
Prestwick_405
Pronison
Pronisone
Rayos
Rectodelt
Retrocortine
S1622_Selleck
SAM002264641
SK-Prednisone
SMR000718760
SMR001227202
SPBio_002214
Servisone
Sone
Sterapred
Supercortil
U 6020
UNII-VB0R961HZT
Ultracorten
Ultracortene
WLN: L E5 B666 CV OV AHTTT&J A1 E1 FV1Q FQ
Winpred
Wojtab
ZINC03875357
Zenadrid
Zenadrid (veterinary)
Zenadrid [veterinary]
delta cortelan
delta(sup 1)-Cortisone
delta(sup 1)-Dehydrocortisone
delta-1-Cortisone
delta-1-Dehydrocortisone
delta-Cortisone
delta-Cortone
4
Folic Acidapproved, nutraceuticalPhase 3292459-30-36037
Synonyms:
(2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid
01769_FLUKA
2d0k
33609-88-0
36653-55-1 (mono-potassium salt)
59-30-3
6484-89-5 (mono-hydrochloride salt)
AC-11682
AC1L1LNX
AI3-26387
AKOS000503224
ARONIS014410
Acfol (Spain)
Acide folique
Acide folique [INN-French]
Acido folico
Acido folico [INN-Spanish]
Acidum folicum
Acidum folicum [INN-Latin]
Acifolic
Antianemia factor
Apo-Folic
BIDD:ER0563
BIDD:GT0641
BIF0608
BPBio1_000654
BSPBio_000594
BSPBio_002338
C00504
C20H20N6O6
CAS-59-30-3
CCRIS 666
CHEBI:27470
CHEMBL1622
CID6037
CPD000471860
Cytofol
D00070
DB00158
DivK1c_000494
Dosfolat B activ
EINECS 200-419-0
F0043
F7876_SIAL
F7876_SIGMA
F8758_SIGMA
F8798_SIAL
F8890_SIGMA
FOL
Facid
Factor U
Folacid
Folacin
Folaemin
Folaemin [Netherlands]
Folan
Folasic (Australia)
Folate
Folbal
Folcidin
Folcidin (VAN)
Folcysteine
Foldine
Foldine [France]
Folettes
Foliamin
Folic
Folic Acid
Folic acid
Folic acid (JP15/USP/INN)
Folic acid (TN)
Folic acid [BAN:INN:JAN]
Folic acid [INN:BAN:JAN]
Folic acid dihydrate
Folicet
Folicet (TN)
Folico
Folico (Italy)
Folina
Folina (Italy)
Folipac
 
Folsaeure
Folsan
Folsaure
Folsav
Folvite
Folvron
Glutamic acid, N-(p-(((2-amino-4-hydroxypyrimido(4,5-b)pyrazin-6-yl)methyl)amino)benzoyl)-, L
HMS1921D20
HMS2092N17
HMS501I16
HSDB 2002
IDI1_000494
InChI=1/C19H19N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,8,12,21H,5-7H2,(H,24,29)(H,27,28)(H,31,32)(H3,20,22,25,26,30)/t12-/m0/s
Incafolic
KBio1_000494
KBio2_001861
KBio2_004429
KBio2_006997
KBio3_001558
KBioGR_002222
KBioSS_001861
Kyselina listova
Kyselina listova [Czech]
LS-2157
Liver Lactobacillus casei factor
MLS001304016
MLS001335861
Millafol
Mission prenatal
Mittafol
MolPort-004-285-551
N-(4-(((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzo- yl)-L-glutamic acid
N-(4-((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-(4-{[(2-Amino-4-oxo-3,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(p-(((2-Amino-4-hydroxy-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-Pteroyl-L-glutamic acid
N-[(4-{[(2-Amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[4-[[(2-Amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-L-glutamic acid
NCGC00016265-01
NCGC00142391-01
NINDS_000494
NSC 3073
Nifolin
Nifolin [Denmark]
Novofolacid
Novofolacid [Canada]
PGA
PGA (VAN)
Prestwick3_000627
Prestwick_230
PteGlu
Pteroyl-L-glutamate
Pteroyl-L-glutamic acid
Pteroyl-L-monoglutamate
Pteroyl-L-monoglutamic acid
Pteroylglutamate
Pteroylglutamic acid
Pteroylmonoglutamate
Pteroylmonoglutamic acid
SAM002264616
SDCCGMLS-0066738.P001
SMP2_000137
SMR000471860
SPBio_001357
SPECTRUM1502020
Serum Folate Level
Spectrum2_001459
Spectrum3_000749
Spectrum4_001751
Spectrum5_000602
Spectrum_001381
UNII-935E97BOY8
Usaf cb-13
Vitamin B11
Vitamin B9
Vitamin Bc
Vitamin Be
Vitamin M
bmse000299
folic acid
nchembio.108-comp10
5Vitamin B ComplexPhase 32847
6Nucleic Acid Synthesis InhibitorsPhase 33836
7AntimetabolitesPhase 39454
8Immunosuppressive AgentsPhase 310422
9Immunologic FactorsPhase 3, Phase 218483
10Folic Acid AntagonistsPhase 31643
11Antimetabolites, AntineoplasticPhase 35770
12Vitamin B9NutraceuticalPhase 32924
13Folinic AcidNutraceuticalPhase 32604
14FolateNutraceuticalPhase 32924
15Pharmaceutical SolutionsPhase 27004
16ImmunoglobulinsPhase 24477
17Antibodies, MonoclonalPhase 22413
18AntibodiesPhase 24477

Interventional clinical trials:

idNameStatusNCT IDPhase
1Autoimmunity in Inner Ear DiseaseTerminatedNCT00000361Phase 3
2A Clinical Trial of Anakinra for Steroid-Resistant Autoimmune Inner Ear DiseaseCompletedNCT01267994Phase 1, Phase 2
3The Effects of Gevokizumab in Corticosteroid-resistant Subjects With Autoimmune Inner Ear DiseaseCompletedNCT01950312Phase 2
4Intratympanic Injection for Autoimmune Inner Ear DiseaseTerminatedNCT01526174Phase 1, Phase 2
5Pilot Study of Raptiva to Treat Sjogren's SyndromeTerminatedNCT00344448Phase 2
6Quantified Balance Measures During Stance and Gait: Multiple Sclerosis Patients. A Longitudinal Clinical StudyRecruitingNCT02142946
7Epidemiological, Clinical and Etiological Features of SUSAC's SyndromeRecruitingNCT01481662
8Strength Training on Pancreatic CancerWithdrawnNCT01395563

Search NIH Clinical Center for Autoimmune Inner Ear Disease

Genetic Tests for Autoimmune Inner Ear Disease

About this section

Anatomical Context for Autoimmune Inner Ear Disease

About this section

MalaCards organs/tissues related to Autoimmune Inner Ear Disease:

33
Liver, Placenta, Endothelial, Neutrophil, T cells, Testes, Prostate

Animal Models for Autoimmune Inner Ear Disease or affiliated genes

About this section

Publications for Autoimmune Inner Ear Disease

About this section

Articles related to Autoimmune Inner Ear Disease:

(show top 50)    (show all 66)
idTitleAuthorsYear
1
Pulmonary Paragonimiasis: The Detection of a Worm Migration Track as a Diagnostic Clue for Uncertain Eosinophilic Pleural Effusion. (26935371)
2016
2
Effect of Creosote Bush-Derived NDGA on Expression of Genes Involved in Lipid Metabolism in Liver of High-Fructose Fed Rats: Relevance to NDGA Amelioration of Hypertriglyceridemia and Hepatic Steatosis. (26394137)
2015
3
Lipoid pneumonia as a complication of Lorenzo's oil therapy in a patient with adrenoleukodystrophy. (24992138)
2014
4
The effect of STAT3 inhibition on status epilepticus and subsequent spontaneous seizures in the pilocarpine model of acquired epilepsy. (24051278)
2014
5
Experimental autoimmune prostatitis induces microglial activation in the spinal cord. (25263093)
2014
6
The management gram-negative bacterial haematogenous vertebral osteomyelitis: a case series of diagnosis, treatment and therapeutic outcomes. (23543389)
2013
7
Outcome of prolactinoma after pregnancy and lactation: a study on 73 patients. (24256562)
2013
8
Acupuncture for lateral epicondylitis (tennis elbow): study protocol for a randomized, practitioner-assessor blinded, controlled pilot clinical trial. (23768129)
2013
9
A multidisciplinary approach to desmoid tumors. When intra-abdominal fibromatosis degenerates into an abscess, which is the right treatment? (23856253)
2013
10
TGF-I^-miR-34a-CCL22 signaling-induced Treg cell recruitment promotes venous metastases of HBV-positive hepatocellular carcinoma. (22975373)
2012
11
Reporter mutation studies show that nicotinic acetylcholine receptor (nAChR) I+5 Subunits and/or variants modulate function of I+6*-nAChR. (21873428)
2011
12
PLU1 histone demethylase decreases the expression of KAT5 and enhances the invasive activity of the cells. (21574959)
2011
13
Expression of activated signal transducer and activator of transcription-3 predicts poor prognosis in cervical squamous-cell carcinoma. (19638983)
2009
14
Influence of clinical and genetic factors on warfarin dose requirements among Japanese patients. (19582440)
2009
15
Mutation analysis of the PAX6 gene in a family with congenital aniridia and cataract]. (19806578)
2009
16
Toxicity associated with the long-term use of targeted therapies in patients with advanced renal cell carcinoma. (19496716)
2009
17
Cohort study of fatty acid synthase expression and patient survival in colon cancer. (18955444)
2008
18
Major depressive disorder, obsessive-compulsive disorder, and generalized anxiety disorder: do the sexual dysfunctions differ? (18787674)
2008
19
Receptor expression is essential for proliferation induced by dimerized Jak kinases. (18381062)
2008
20
The incidence of primary fallopian tube cancer in the United States. (17961642)
2007
21
Association of CYP1B1 germ line mutations with hepatocyte nuclear factor 1alpha-mutated hepatocellular adenoma. (17363580)
2007
22
Adenovirus vectors based on human adenovirus type 19a have high potential for human muscle-directed gene therapy. (16454653)
2006
23
Metal-binding properties of human centrin-2 determined by micro-electrospray ionization mass spectrometry and UV spectroscopy. (16750384)
2006
24
Tropical spastic paraparesis from northern India. (17212030)
2006
25
Facilitating physiologic self-regeneration: a step beyond islet cell replacement. (16323065)
2006
26
Vascular endothelial growth factor-C expression and invasive phenotype in ovarian carcinomas. (15867217)
2005
27
R-ras as a key player for signaling pathway of plexins. (16385138)
2005
28
An annexin 1 N-terminal peptide activates leukocytes by triggering different members of the formyl peptide receptor family. (15187149)
2004
29
A redox-sensitive loop regulates plasminogen activator inhibitor type 2 (PAI-2) polymerization. (12682008)
2003
30
Vesicoureteral reflux in patients with posterior urethral valves. (14501690)
2003
31
PRV-1 mRNA expression and other molecular markers in polycythemia rubra vera. (12901344)
2003
32
Induction of follicular development by direct single injection of vascular endothelial growth factor gene fragments into the ovary of miniature gilts. (12826586)
2003
33
Perioperative detection of circulating cancer cells in patients with colorectal hepatic metastases. (12397747)
2002
34
Epiblepharon of the lower eyelid: technique of surgical repair and quantification of excision according to the skin fold height. (12134986)
2002
35
How do Rho family GTPases direct axon growth and guidance? A proposal relating signaling pathways to growth cone mechanics. (12366376)
2002
36
Reiter's syndrome and reactive arthritis. (10732393)
2000
37
X-linked agammaglobulinaemia and the underlying genetics in two kindreds. (11036800)
2000
38
The human and mouse MHC class III region: a parade of 21 genes at the centromeric segment. (10871871)
2000
39
Peroxynitrite-mediated nitration of the stable free radical tyrosine residue of the ribonucleotide reductase small subunit. (10769119)
2000
40
Partial characterization of the active site human platelet cAMP phosphodiesterase, PDE3A, by site-directed mutagenesis. (9826434)
1998
41
Characterization of glycine-N-methyltransferase-gene expression in human hepatocellular carcinoma. (9495250)
1998
42
Tachykinin peptides affect differently the second messenger pathways after binding to CHO-expressed human NK-1 receptors. (8786533)
1996
43
Cytotoxic drugs plus subcutaneous granulocyte-macrophage colony-stimulating factor: can molgramostim enhance antisarcoma therapy? (8158688)
1994
44
Synergistic calcium release in the sea urchin egg by ryanodine and cyclic ADP ribose. (8174765)
1994
45
Seeming homozygosity in type-IIB von Willebrand's disease due to a polymorphism within the sequence of a commonly used primer. (7909449)
1994
46
Dysregulation of strongyloidiasis: a new hypothesis. (1423214)
1992
47
Visualization of fetal intra-abdominal organs in second-trimester severe oligohydramnios by intraperitoneal infusion. (2652131)
1989
48
The dexamethasone suppression test and defining melancholia. (4003605)
1985
49
Chronic discoid lupus erythematosus in children. (5695138)
1968
50
Liver extract refractory megaloblastic anemia. (18139384)
1949

Variations for Autoimmune Inner Ear Disease

About this section

Expression for genes affiliated with Autoimmune Inner Ear Disease

About this section
Search GEO for disease gene expression data for Autoimmune Inner Ear Disease.

Pathways for genes affiliated with Autoimmune Inner Ear Disease

About this section

GO Terms for genes affiliated with Autoimmune Inner Ear Disease

About this section

Sources for Autoimmune Inner Ear Disease

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet